These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28891392)

  • 1. ESR2 Gene and Medullary Thyroid Carcinoma.
    Ruiz-Ferrer M; Fernández RM; Navarro E; Antiñolo G; Borrego S
    Thyroid; 2017 Nov; 27(11):1456-1457. PubMed ID: 28891392
    [No Abstract]   [Full Text] [Related]  

  • 2. Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.
    Smith J; Read ML; Hoffman J; Brown R; Bradshaw B; Campbell C; Cole T; Navas JD; Eatock F; Gundara JS; Lian E; Mcmullan D; Morgan NV; Mulligan L; Morrison PJ; Robledo M; Simpson MA; Smith VE; Stewart S; Trembath RC; Sidhu S; Togneri FS; Wake NC; Wallis Y; Watkinson JC; Maher ER; McCabe CJ; Woodward ER
    Hum Mol Genet; 2016 May; 25(9):1836-45. PubMed ID: 26945007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medullary and non-medullary thyroid cancer in a family.
    Ardern-Jones A; Harvey RJ; Wilson P; Sharma AK; Murday V; Harmer C; Houlston RS
    Acta Oncol; 2004; 43(7):680-1. PubMed ID: 15545189
    [No Abstract]   [Full Text] [Related]  

  • 4. A perspective from pediatric endocrinology on the hereditary medullary thyroid carcinoma syndromes.
    Waguespack SG
    Thyroid; 2009 Jun; 19(6):543-6. PubMed ID: 19499985
    [No Abstract]   [Full Text] [Related]  

  • 5. Medullary carcinoma of the thyroid: subtypes and current management.
    Randolph GW
    Compr Ther; 1996 Apr; 22(4):203-10. PubMed ID: 8733776
    [No Abstract]   [Full Text] [Related]  

  • 6. RET activation in medullary carcinomas.
    Pierotti MA; Arighi E; Degl'innocenti D; Borrello MG
    Cancer Treat Res; 2004; 122():389-415. PubMed ID: 16209058
    [No Abstract]   [Full Text] [Related]  

  • 7. Aggressive medullary thyroid carcinoma in a ten-year-old patient with multiple endocrine neoplasia 2B due to the A883F mutation.
    Mathiesen JS; Stochholm K; Poulsen PL; Vestergaard EM; Christiansen P; Vestergaard P
    Thyroid; 2015 Jan; 25(1):139-40. PubMed ID: 25244518
    [No Abstract]   [Full Text] [Related]  

  • 8. Mixed medullary and follicular carcinoma of the thyroid. On the search for its histogenesis.
    Matias-Guiu X
    Am J Pathol; 1999 Nov; 155(5):1413-8. PubMed ID: 10550294
    [No Abstract]   [Full Text] [Related]  

  • 9. Sporadic medullary thyroid cancer.
    Harvey A; Pasieka JL
    Cancer Treat Res; 2010; 153():57-74. PubMed ID: 19957219
    [No Abstract]   [Full Text] [Related]  

  • 10. Medullary thyroid carcinoma: a continuing medical education case.
    Stewart J; Sun MC; Kurtycz DF
    Diagn Cytopathol; 2007 Dec; 35(12):810-4; quiz 815-6. PubMed ID: 18008350
    [No Abstract]   [Full Text] [Related]  

  • 11. [Medullary thyroid carcinoma: evolution of concepts].
    Franc B; Modigliani E
    Arch Anat Cytol Pathol; 1998; 46(1-2):100-11. PubMed ID: 9754365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathology of hereditary and sporadic medullary thyroid carcinomas.
    Chernock RD; Hagemann IS
    Am J Clin Pathol; 2015 Jun; 143(6):768-77. PubMed ID: 25972318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2B].
    Mathiesen JS; Døssing H; Bender L; Godballe C
    Ugeskr Laeger; 2014 Jan; 176(5A):. PubMed ID: 27498810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of atrial natriuretic peptide in rat thyroid medullary carcinoma cell line.
    Maekawa T; Fukui H; Okada A; Kinoshita Y; Ono Y; Fujimori T; Chiba T
    Acta Oncol; 1998; 37(5):500-2. PubMed ID: 9831383
    [No Abstract]   [Full Text] [Related]  

  • 16. Medullary thyroid carcinoma.
    Modigliani E
    Curr Ther Endocrinol Metab; 1994; 5():112-7. PubMed ID: 7704692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medullary thyroid carcinoma and other rare types of thyroid carcinoma].
    Obara T
    Nihon Rinsho; 2007 Nov; 65(11):2087-91. PubMed ID: 18018575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer.
    Liska J; Altanerova V; Galbavy S; Stvrtina S; Brtko J
    Endocr Regul; 2005 Sep; 39(3):73-83. PubMed ID: 16468229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
    Chi DD; Moley JF
    Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.